Cej. Van Rensburg et al., Clofazimine and B4121 sensitize an intrinsically resistant human colon cancer cell line to P-glycoprotein substrates, ONCOL REP, 7(1), 2000, pp. 193-195
The potential of B4121 to sensitize three intrinsically resistant human col
on cancer cell lines (CaCo2, ATCC HTB 37; COLO 32 DM, ATCC CCL 220; HT-29,
ATCC HTB 38) to vinblastine, doxorubicin, daunorubicin, paclitaxel, taxoter
e and cisplatin at a non-toxic, therapeutically relevant concentration of 0
.25 mu g/ml was compared with that of clofazimine at a similar concentratio
n. The cell line expressing high levels of P-glycoprotein (P-gp), COLO 320
DM, was susceptible to chemosensitization by the experimental agents for th
e P-gp substrates (paclitaxel, taxotere, daunorubicin, vinblastine and doxo
rubicin) but not for cisplatin. CaCo2 cells expressed lower levels of P-gp
and were only marginally susceptible to sensitization by any one of these d
rugs, except in the case of sensitization by B4121 for doxorubicin and taxo
tere, whereas the HT-29, a P-gp negative cell line, was unaffected. The rim
inophenazines, especially B4121, might prove useful as combination treatmen
t in circumventing P-gp mediated resistance of colon cancers.